Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-24 @ 9:22 PM
NCT ID:
NCT02563704
Eligibility Criteria:
Inclusion Criteria:
* Children presenting with one or more signs of severity of malaria according to the 2013 Cameroon National Malaria Control Programme adopted criteria (impaired consciousness, abnormal behaviour, convulsions, prostration, persistent vomiting, jaundice, hyperthermia, acute respiratory distress, clinical acidosis, haemoglobinuria, cardiovascular shock, dehydration, abnormal bleeding, severe anaemia, renal impairment, hypoglycaemia and hyperparasitaemia)
* and having an initial positive parasitaemia to Plasmodium falciparum
* Other aetiologies of the presenting symptoms excluded
* Written consent from parent(s)
Exclusion Criteria:
* Prior side effects to either artesunate or quinine administration
* Severely malnourished children
* Concomitant infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Months
Maximum Age:
15 Years
Study:
NCT02563704
Study Brief:
Protocol Section:
NCT02563704